These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 20685203)
1. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents. Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203 [TBL] [Abstract][Full Text] [Related]
2. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570 [TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi. de Oliveira-Silva F; de Morais-Teixeira E; Rabello A Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis. Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365 [TBL] [Abstract][Full Text] [Related]
5. Leishmania (Viannia) peruviana (MHOM/PE/LCA08): comparison of THP-1 cell and murine macrophage susceptibility to axenic amastigotes for the screening of leishmanicidal compounds. González G; Castillo D; Estevez Y; Grentzinger T; Deharo E Exp Parasitol; 2009 Aug; 122(4):353-6. PubMed ID: 19460378 [TBL] [Abstract][Full Text] [Related]
6. Glucantime susceptibility of Leishmania promastigotes under variable growth conditions. Moreira ES; Soares RM; Petrillo-Peixoto Mde L Parasitol Res; 1995; 81(4):291-5. PubMed ID: 7624285 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions. Ayres DC; Pinto LA; Giorgio S J Parasitol; 2008 Dec; 94(6):1415-7. PubMed ID: 18576874 [TBL] [Abstract][Full Text] [Related]
8. Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug. Varela M RE; Muñoz DL; Robledo SM; Kolli BK; Dutta S; Chang KP; Muskus C Exp Parasitol; 2009 Jun; 122(2):134-9. PubMed ID: 19303871 [TBL] [Abstract][Full Text] [Related]
9. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Paila YD; Saha B; Chattopadhyay A Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487 [TBL] [Abstract][Full Text] [Related]
10. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages. Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Sensitivity of Cutaneous Ginouvès M; Simon S; Nacher M; Demar M; Carme B; Couppié P; Prévot G Am J Trop Med Hyg; 2017 May; 96(5):1143-1150. PubMed ID: 28167598 [TBL] [Abstract][Full Text] [Related]
12. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Yardley V; Croft SL; De Doncker S; Dujardin JC; Koirala S; Rijal S; Miranda C; Llanos-Cuentas A; Chappuis F Am J Trop Med Hyg; 2005 Aug; 73(2):272-5. PubMed ID: 16103588 [TBL] [Abstract][Full Text] [Related]
13. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Pulido SA; Muñoz DL; Restrepo AM; Mesa CV; Alzate JF; Vélez ID; Robledo SM Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571 [TBL] [Abstract][Full Text] [Related]
14. 7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compounds. Coimbra ES; Antinarelli LM; da Silva AD; Bispo ML; Kaiser CR; de Souza MV Chem Biol Drug Des; 2013 May; 81(5):658-65. PubMed ID: 23350797 [TBL] [Abstract][Full Text] [Related]
15. Glucantime resistant Leishmania promastigotes are sensitive to pentostam. Moreira ES; Guerra JB; Petrillo-Peixoto Mde L Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539 [TBL] [Abstract][Full Text] [Related]
16. A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery. Pineda T; Valencia Y; Flórez MF; Pulido SA; Vélez ID; Robledo SM Parasitology; 2016 Aug; 143(9):1133-42. PubMed ID: 27174193 [TBL] [Abstract][Full Text] [Related]
17. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. Jain SK; Sahu R; Walker LA; Tekwani BL J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097 [TBL] [Abstract][Full Text] [Related]